EssilorLuxottica gets A+ rating and EssilorLuxottica stock trades at EUR 175.25

Published on 10/27/2026 at 09:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine-month revenue reached EUR 22.30 billion, up 6.80 percent. EssilorLuxottica stock costs EUR 175.25 on October 27, 2026 alongside 9.0 percent Q3 growth.

Credit strength meets operating growth

On October 23, 2026, EssilorLuxottica announced an upgrade to A+ with a stable outlook.
Third-quarter revenue reached EUR 7,486 million, up 9.0 percent at current exchange rates.
EssilorLuxottica stock trades at EUR 175.25 at 9:46 a.m. CET at Lang & Schwarz on October 27, 2026.
Wearables revenue rose 20 percent in the third quarter of 2026.

EssilorLuxottica S.A., FR0000121667, Illustration mit AI erstellt.

EssilorLuxottica (ISIN FR0000121667) received an A+ long-term credit rating with a stable outlook on October 23, 2026, according to the company announcement published by GlobeNewswire. The upgrade gives EssilorLuxottica a stronger credit profile as its latest operating figures show continued expansion.

Credit upgrade reflects business strength

The company said the rating action reflects its organic growth trajectory, sound cash flow and strong balance sheet. S&P Global Ratings raised the long-term issuer rating to A+ from A and affirmed the A-1 short-term rating.

S&P Global Ratings also described the group as increasingly integrated across eyecare and medtech. Its report assigns 94 percent of total sales to the core offering and 6 percent to wearables in year-to-date 2026, making the traditional business the larger support for the rating.

Revenue growth broadens the case

EssilorLuxottica reported third-quarter revenue of EUR 7,486 million, up 9.0 percent at current exchange rates and 7.2 percent at constant exchange rates, in the EssilorLuxottica release dated October 20, 2026. Revenue for the first nine months reached EUR 22,304 million, up 6.8 percent at current exchange rates and 8.9 percent at constant exchange rates.

The mix adds a second growth engine. Direct-to-consumer revenue rose 10.6 percent in the third quarter, while wearables revenue increased 20 percent and the myopia-management portfolio grew 24 percent.

What supports the rating view?

The rating rationale points to resilient prescription products, cash generation and product innovation rather than a single smart-glasses trend. That distinction matters because the latest release shows traditional eyecare and medtech growing more than 6 percent in both the quarter and the first nine months of 2026.

Stock quote on October 27

EssilorLuxottica stock was trading at EUR 175.25 at Lang & Schwarz on October 27, 2026 at 9:46 a.m. CET. The quote places the market reaction alongside a newly upgraded credit profile and a third quarter with 9.0 percent revenue growth.

The further course of trading is shown by the continuously updated real-time quote of EssilorLuxottica stock.